Immunic, Inc. - Common Stock, par value $0.0001 per share (IMUX)

CUSIP: 4525EP101

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 6 signals
Share change
+763,433
SEC-reported price per share
$9.57
Indexed holders
66
Value change
+$7,603,275
Number of buys
36
Number of sells
27
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
13,669,957

Security key

4525EP101

Report period

Q4 2021

Indexed institutions

66

Top holders

10

Ownership snapshot

Top reported holders of IMUX - Immunic, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Omega Fund Management, LLC
Disclosed value leader
Omega Fund Management, LLC
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F Highest disclosed value: $15,825,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Omega Fund Management, LLC has the largest disclosed position value at $15.82M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Omega Fund Management, LLC's linked filing trail.
Disclosed position value Top 5
Omega Fund Management, LLC $15.82M
RTW INVESTMENTS, LP $12.13M
BlackRock Finance, Inc. $11.07M
FMR LLC $9.43M
Parkman Healthcare Partners LLC $8.18M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Omega Fund Management, LLC
13F
Company
13F
—
denominator unverified
$15,825,000
1,788,160 shares
— 30 Sep 2021
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$12,132,000
1,370,814 shares
— 30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$11,073,000
1,251,145 shares
— 30 Sep 2021
FMR LLC
13F
Company
13F
—
denominator unverified
$9,427,000
1,065,289 shares
— 30 Sep 2021
Parkman Healthcare Partners LLC
13F
Company
13F
—
denominator unverified
$8,178,000
924,087 shares
— 30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$7,798,000
881,205 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
66
Shares
13,709,674
Indexed holders
66
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 indexed holders
66
Q4 2021 indexed holders
66
Indexed holder difference
0
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .